Skip to main content

Advertisement

SpringerLink
Log in

SSTR antagonist [68Ga]Ga-DOTA-LM3 differentiates intrapancreatic accessory spleen from neuroendocrine tumor in a patient presenting indeterminate MRI and SSTR agonist [68Ga]Ga-DOTATATE

  • Image of the Month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data Availability

The data underlying this article will be shared on reasonable request to the corresponding author.

References

  1. Bostanci EB, Oter V, Okten S, Kucuk NO, Soydal C, Turhan N, et al. Intra-pancreatic accessory spleen mimicking pancreatic neuroendocrine tumor on 68-Ga-dotatate PET/CT. Arch Iran Med. 2016;19:816–9.

    PubMed  Google Scholar 

  2. Guo W, Chen Y, He X, Fu H, Huang J, Chen H. [(68) Ga]Ga-DOTATATE PET/CT versus [(68) Ga]Ga-exendin-4 PET/CT in the evaluation of metastatic insulinoma. Eur J Nucl Med Mol Imaging. 2023;50:2910–1. https://doi.org/10.1007/s00259-023-06182-8.

    Article  CAS  PubMed  Google Scholar 

  3. Pang Y, Meng T, Shang Q, Chen Z, Chen H. 68Ga-Exendin-4 PET/CT differentiates insulinoma from accessory spleen in a patient presenting indeterminate MRI and 68Ga-DOTATATE PET/CT findings. Clin Nucl Med. 2022;47:265–7. https://doi.org/10.1097/RLU.0000000000003895.

    Article  PubMed  Google Scholar 

  4. Zhu W, Cheng Y, Jia R, Zhao H, Bai C, Xu J, et al. A prospective, randomized, double-blind study to evaluate the safety, biodistribution, and dosimetry of (68)Ga-NODAGA-LM3 and (68)Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors. J Nucl Med. 2021;62:1398–405. https://doi.org/10.2967/jnumed.120.253096.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhu W, Jia R, Yang Q, Cheng Y, Zhao H, Bai C, et al. A prospective randomized, double-blind study to evaluate the diagnostic efficacy of (68)Ga-NODAGA-LM3 and (68)Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with (68)Ga-DOTATATE. Eur J Nucl Med Mol Imaging. 2022;49:1613–22. https://doi.org/10.1007/s00259-021-05512-y.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Weizhi Xu and Jiayu Cai contributed equally to this work.

Authors and Affiliations

  1. Department of Nuclear Medicine and Minnan PET Center, Xiamen Key Laboratory of Radiopharmaceuticals, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

    Weizhi Xu, Jiayu Cai, Tinghua Meng, YiZhen Pang & Haojun Chen

Authors
  1. Weizhi Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jiayu Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tinghua Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. YiZhen Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Haojun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haojun Chen.

Ethics declarations

Informed consent and ethics approval

This study was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital of Xiamen University, and written informed consent for publication of this report was obtained from the patient.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, W., Cai, J., Meng, T. et al. SSTR antagonist [68Ga]Ga-DOTA-LM3 differentiates intrapancreatic accessory spleen from neuroendocrine tumor in a patient presenting indeterminate MRI and SSTR agonist [68Ga]Ga-DOTATATE. Eur J Nucl Med Mol Imaging 51, 606–608 (2024). https://doi.org/10.1007/s00259-023-06428-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-023-06428-5

Search

Navigation